©The Author(s) 2025.
World J Clin Cases. Sep 6, 2025; 13(25): 107907
Published online Sep 6, 2025. doi: 10.12998/wjcc.v13.i25.107907
Published online Sep 6, 2025. doi: 10.12998/wjcc.v13.i25.107907
Table 4 Levels of prostaglandins on lung cancer models
| Factor | Models | Levels | Ref. |
| Prostaglandin D2 | Lung cancer tissue | Low | [85] |
| NSCLC | Low | [86] | |
| Prostaglandin I2 | Lung cancer patient | Low | [87] |
| neoplastic cell | Low | [88] | |
| Lung cancer patient | High | [89] | |
| Lung tumor tissue | Low | [90] | |
| Prostaglandin E2 | lung cancer tissue | High | [91] |
| NSCLC cell line | High | [92] | |
| Lung cancer tissue | High | [85] | |
| Lung cancer patient | high | [93] | |
| NSCLC patient | High | [94] | |
| 8-Iso-prostaglandin F2α | Lung cancer patient | High | [95] |
| Lung cancer patient | High | [96] | |
| NSCLC patient | High | [97] | |
| Lung cancer patient | High | [98] | |
| NSCLC patient | High | [99] |
- Citation: Demirel S, Sinag IN. Role of nitric oxide, prostaglandins, thromboxanes and endothelins in lung cancer: An overview. World J Clin Cases 2025; 13(25): 107907
- URL: https://www.wjgnet.com/2307-8960/full/v13/i25/107907.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i25.107907